FDA Tells Patients to Stick With Diabetes Drug Linked to Cancer

Related Encyclopedia • Addison's Disease • Adenocarcinoma of the Lung and Brain Metastases • Basal Cell Carcinoma • Bladder Cancer More... Related Healthscout Videos Skin Cancer: It's About the ABC's Roadmap for the Brain Kids Diagnosing Themselves Tracking Breast Cancer with Less Pain More... Related Animations • Breast Self-Exam Video • Colon Cancer • Diabetes More... Related Drug Information • Actonel • Actos • Amaryl • Avandamet More... Related News Articles • Lymphoma Survivors Often Miss Out on Follow-Up • Coffee Might Guard Against Head, Neck Cancers • Patients Could Use More Help Quitting Smoking • Hopes Dashed That Vitamin D Reduces Cancer Risk More...

Page:  << Prev | 1 | 2

The FDA says it is "currently reviewing many sources of safety data for Lantus," including completed and ongoing observational and clinical trials, and may ask Sanofi to conduct further trials should they be deemed necessary.

According to the Wall Street Journal, a spokesman for Sanofi said that the company is working with the FDA on this issue and continues to stand behind the drug's safety.

In the meantime, the FDA says it "encourages both health care professionals and patients to report side effects from the use of insulin glargine to the FDA's MedWatch Adverse Event Reporting Program."

Text Continues Below

---

More information

Find out more about diabetes at the American Diabetes Association.

Page:  << Prev | 1 | 2

-- E.J. Mundell